Cargando…
Synthesis, Conformation, and Activity of Human Insulin-Like Peptide 5 (INSL5)
Insulin-like peptide 5 (INSL5) was first identified through searches of the expressed sequence tags (EST) databases. Primary sequence analysis showed it to be a prepropeptide that was predicted to be processed in vivo to yield a two-chain sequence (A and B) that contained the insulin-like disulfide...
Autores principales: | Hossain, Mohammed Akhter, Bathgate, Ross A D, Kong, Chze K, Shabanpoor, Fazel, Zhang, Suode, Haugaard-Jönsson, Linda M, Rosengren, K Johan, Tregear, Geoffrey W, Wade, John D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699039/ https://www.ncbi.nlm.nih.gov/pubmed/18576448 http://dx.doi.org/10.1002/cbic.200800113 |
Ejemplares similares
-
C-Terminus of the B-Chain of Relaxin-3 Is Important for Receptor Activity
por: Shabanpoor, Fazel, et al.
Publicado: (2013) -
Total Chemical Synthesis of a Heterodimeric Interchain Bis-Lactam-Linked Peptide: Application to an Analogue of Human Insulin-Like Peptide 3
por: Karas, John, et al.
Publicado: (2013) -
The Structural Determinants of Insulin-Like Peptide 3 Activity
por: Bathgate, Ross A. D., et al.
Publicado: (2012) -
Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling
por: Li, Shi‐Bing, et al.
Publicado: (2020) -
Exploring the Use of Helicogenic Amino Acids for Optimising Single Chain Relaxin-3 Peptide Agonists
por: Lee, Han Siean, et al.
Publicado: (2020)